Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Orthop Traumatol Surg Res ; 98(6): 696-705, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22951052

ABSTRACT

BACKGROUND: Clostridium spp. are saprophytic Gram-positive bacteria found in soil and capable of generating endospores. Spore germination occurs when environmental conditions are favorable. Clostridium spp. can cause infections of compound fractures and deep wounds contaminated from soil micro-organisms. HYPOTHESIS: Clostridium spp. infections of traffic-related injuries are particularly severe events whose outcome is uncertain even with aggressive medical and surgical treatment. MATERIALS AND METHODS: We retrospectively reviewed 12 patients (median age, 45 years) with Clostridium spp. bone and/or joint infections complicating compound limb fractures with soil contamination and extensive soft-tissue damage. Prophylactic amoxicillin-clavulanic acid therapy was administred, followed by emergency surgical wound debridment and lavage. Fracture fixation was performed immediately in nine patients (external in four and internal in five) or at a later time on three patients. The immediate outcome was unfavourable in all 12 cases, requiring early reoperation after a median of 10 days (range, 5-25 days). RESULTS: Median time to Clostridium strain identification was 14.5 days (range, 5-160). All infections were polymicrobial. Surgical wound excision, hardware removal (in four cases), and antibiotic therapy produced a favourable outcome in one patient, with no recurrence after 2 years of follow-up; the outcome was unfavourable in 11 cases, with delayed fracture union, septic non-union, impaired healing, and/or chronic sinus tract drainage. Several second-line treatments were used in these 11 patients: intramedullary nailing without bone grafting in four patients, with three failures; decortication and grafting in two patients, with failure in both; nailing with decortication in one patient, who had a good outcome; and the induced membrane procedure described by Masquelet in four patients, all of whom had good outcomes. After a median follow-up of 24 months (range, 18-53 months), the bone infection had subsided in eight patients. The remaining four patients had septic non-union. DISCUSSION: Clostridium spp. infections are particularly severe. The diagnosis is delayed and identification of the organism is challenging. The treatment is difficult and results in unfavorable outcomes in one-third of cases. The identification of Clostridium in specimens from an osteoarticular infection indicates a need for extremely extensive and aggressive surgical resection, as spore resistance may impair the in vivo efficacy of antimicrobial agents. LEVEL OF EVIDENCE: IV (retrospective cohort study).


Subject(s)
Arm Injuries/surgery , Clostridium Infections/epidemiology , Clostridium/isolation & purification , Fracture Fixation/adverse effects , Fractures, Bone/surgery , Leg Injuries/surgery , Wound Healing , Adolescent , Adult , Aged , Clostridium Infections/microbiology , Female , France/epidemiology , Humans , Incidence , Male , Middle Aged , Retrospective Studies , Young Adult
2.
J Antimicrob Chemother ; 65(12): 2650-7, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20876240

ABSTRACT

BACKGROUND: The increase in fluoroquinolone-resistant Escherichia coli has raised the issue of treatment failure in common infections. Few studies have investigated the possible relationship between outpatient fluoroquinolone consumption and resistance in hospital. OBJECTIVE: To investigate the relationship between inpatient and outpatient fluoroquinolone use and ciprofloxacin-resistant E. coli in a teaching hospital. METHODS: An ecological study was conducted in Toulouse University Hospital and its surrounding area, the Midi-Pyrénées region (south-western France), in 2004-07. Dynamic regression models were built to study how the hospital resistance rate was linearly related to current and past values of fluoroquinolone consumption. Resistance forecasts for 2008 were then calculated and compared with actual rates for the first 5 months of the year. RESULTS: Mean resistance rate was 13.7% and mean fluoroquinolone use was 89.9 defined daily doses (DDDs)/1000 inpatient days in hospital and 2.6 DDDs/1000 inhabitants/day in the region. Taking into account past values of fluoroquinolone consumption in hospital and in outpatients, only levofloxacin use in the community remained significantly associated with resistance in hospital, with a lag of 12 months. This model explained 50% of the resistance variability. CONCLUSIONS: This ecological analysis, conducted on a teaching hospital scale, suggests that ciprofloxacin resistance in E. coli in hospital is linked to consumption of fluoroquinolones within the hospital and its surrounding community. Among all fluoroquinolones, levofloxacin use was found to be the most important factor. Consumption in outpatients appears to be a relevant determinant to consider in designing interventions to reduce resistance in hospitals.


Subject(s)
Anti-Infective Agents/pharmacology , Ciprofloxacin/pharmacology , Drug Resistance, Bacterial , Escherichia coli/drug effects , Fluoroquinolones/therapeutic use , Inpatients , Outpatients , Anti-Infective Agents/therapeutic use , Drug Utilization/statistics & numerical data , Escherichia coli/isolation & purification , Escherichia coli Infections/drug therapy , Escherichia coli Infections/microbiology , Fluoroquinolones/pharmacology , France , Hospitals, University , Humans , Microbial Sensitivity Tests
3.
Ann Fr Anesth Reanim ; 26(9): 780-3, 2007 Sep.
Article in French | MEDLINE | ID: mdl-17629655

ABSTRACT

OBJECTIVE: To investigate leg fractures infected with Bacillus cereus in a traumatology-orthopedic ward of a university hospital. METHODS: All B. cereus strains isolated from patients with leg fracture hospitalized in the traumatology-orthopedic ward between 1995 and 2004 were included in this retrospective study. RESULTS: Five hundred and four patients had leg fracture during this period. Thirty-four patients were included in this retrospective study. B. cereus strains clinical isolates were mainly isolated from patients who had initially leg fractures with telluric contamination (wound contamination with terrestrial environments) before admission. Betalactam antibiotics used for prophylactic chemotherapy were not effective against B. cereus. CONCLUSION: In this study, we underscore the significance of Sfar recommendations concerning prophylactic chemotherapy. However, B. cereus could be termed an emerging pathogen and physicians need to be aware of its potential importance in trauma cases. In this purpose, a systematic screening for B. cereus at admission should be necessary in front of patients with open fractures associated with telluric contamination. Furthermore, if B. cereus is isolated, chemotherapy should be based upon ciprofloxacin during 2 or 6 weeks.


Subject(s)
Bacillus cereus , Fractures, Open/complications , Gram-Positive Bacterial Infections/etiology , Leg Bones/injuries , Adult , Female , Humans , Male , Retrospective Studies
4.
Infection ; 35(3): 182-5, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17565461

ABSTRACT

We described seven patients with Streptococcus milleri group aortic (six patients) or vena cava (one patient) graft infection secondary to a vasculo-digestive fistula. Time between vascular graft setting and first clinical signs varied from eight months to more than thirteen years. Six patients had fever. Three patients presented with recurrent fever for more than nine months and in two of these cases, delay before diagnosis was long because repeated blood cultures were sterile. Three patients had abdominal pain and/or digestive haemorrhage. Abdominal CT-scan S. milleri was not contributive for the diagnosis in four patients. Streptococcus anginosus was isolated in four patients, Streptococcus constellatus in three patients. One patient died before surgical management. The other six patients were cured by a surgical management associated with a prolonged antibiotic (lactams) treatment. S. milleri group graft infections are rare (or misdiagnosed) while we found only 4 similar cases in the English medical literature. We conclude that a peri-prosthetic infection secondary to a digestive fistula must be insistently searched (and blood cultures must be repeated many times) in any patient with an aortic (or any other vascular) graft presenting prolonged or recurrent fever or acute digestive symptoms.


Subject(s)
Digestive System Fistula/microbiology , Prosthesis-Related Infections/microbiology , Streptococcal Infections/complications , Streptococcus milleri Group/pathogenicity , Vascular Fistula/microbiology , Aged , Anti-Infective Agents/therapeutic use , Digestive System Fistula/complications , Drug Therapy, Combination , Female , Humans , Male , Middle Aged , Prosthesis-Related Infections/drug therapy , Prosthesis-Related Infections/surgery , Vascular Fistula/complications , beta-Lactams/therapeutic use
5.
Int J Clin Pharmacol Ther ; 43(8): 360-9, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16119511

ABSTRACT

The aim of this study was to compare the pharmacokinetic and pharmacodynamic parameters of a continuous infusion of cefepime vs. an intermittent regimen in critically ill adult patients with Gram-negative bacilli infection. The prospective randomized parallel study was carried out in 50 patients with severe pneumonia (n = 41) or bacteremia (n = 9). They received cefepime 4 g/d either as a continuous infusion or intermittent administration 2 x 2 g in combination with amikacin. Patient characteristics and the minimal inhibitory concentration (MIC) of the isolated bacteria were comparable. Clinical outcomes were assessed along with pharmacodynamic indices and compared in both groups (chi2 and Mann-Whitney U-tests). Mechanical ventilation, clinical outcome and bacteriological eradication did not significantly differ between the two groups. Also, the area under the plasma cefepime concentration curve at steady state (AUCss: 612 +/- 369 vs. 623 +/- 319 mg x 1(-1) x h), AUCss > MIC (595 +/- 364 vs. 606 +/- 316 mg x 1(-1) x h) and the area under the inhibitory concentration curve (AUICss: 4258 +/- 5819 vs. 5194 +/- 7465 mg x 1(-1) x h) were similar. If the time above MIC (t > MIC) was not significantly higher in Group 1 (100 +/- 0%) than in Group 2 (90 +/- 11%), t > five-fold MIC in Group 1 (100 +/- 0%) was significantly higher (p < 0.01) than in Group 2 (82 +/- 25%). The mean time over the French breakpoint (4 mg/l) was 100 +/- 0% and 72 +/- 27% in Group 1 and 2 (p < 0.001), respectively. In contrast to intermittent cefepime administration, continuous infusion of cefepime consistently maintained a serum concentration > 5 x the MIC of typical Gram-negative nosocomial pathogens. This results in greater bactericidal activity against organisms with a higher (2 mg/l) cefepime breakpoint even if the clinical outcome is not significantly modified.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Cephalosporins/administration & dosage , Gram-Negative Bacterial Infections/drug therapy , Adult , Aged , Amikacin/administration & dosage , Amikacin/blood , Amikacin/therapeutic use , Anti-Bacterial Agents/blood , Anti-Bacterial Agents/therapeutic use , Area Under Curve , Cefepime , Cephalosporins/blood , Cephalosporins/therapeutic use , Critical Illness , Drug Therapy, Combination , Female , Gram-Negative Bacteria/drug effects , Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacterial Infections/blood , Gram-Negative Bacterial Infections/microbiology , Humans , Infusions, Intravenous , Injections, Intravenous , Male , Microbial Sensitivity Tests , Middle Aged , Prospective Studies , Time Factors , Treatment Outcome
7.
J Infect ; 50(1): 22-30, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15603836

ABSTRACT

OBJECTIVE: To investigate 41 open fractures infected with Bacillus cereus in a Traumatology-Orthopaedy ward and propose a care protocol at admission. METHODS: All B. cereus strains isolated from patients hospitalized in the Traumatology-Orthopaedy ward between March 1997 and August 2001 were submitted to molecular analysis (RAPD and PFGE) in order to investigate a putative outbreak. Susceptibility to the main antibiotics and antiseptics used in this kind of surgery was also evaluated. RESULTS: The B. cereus clinical isolates were mainly isolated from patients who had initially open fractures and were not clonally related. Furthermore, analysis of the clinical data was in favour of a telluric contamination of the wound (wound contamination with terrestrial environments) before admission. Finally, betalactam antibiotics used for prophylactic chemotherapy were not effective against the strains tested as well as the antiseptics who displayed poor effect. CONCLUSION: B. cereus could be termed an emerging pathogen and people need to be aware of its potential importance in orthopaedic trauma cases. In this purpose, a systematic screening for B. cereus at admission should be necessary in front of patients with open fractures associated with telluric contamination. Furthermore, if this bacterium can be isolated, chemotherapy should be based upon ciprofloxacin that would prevent the development of B. cereus infection responsible for deleterious complications.


Subject(s)
Bacillaceae Infections/microbiology , Bacillus cereus , Hospitalization , Orthopedics , Traumatology , Wound Infection/microbiology , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents, Local/pharmacology , Bacillaceae Infections/drug therapy , Bacillus cereus/classification , Bacillus cereus/drug effects , Bacillus cereus/genetics , Bacillus cereus/isolation & purification , Ciprofloxacin/therapeutic use , Delivery of Health Care/standards , Electrophoresis, Gel, Pulsed-Field , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Random Amplified Polymorphic DNA Technique , Retrospective Studies , Soil Pollutants , Wound Infection/drug therapy
8.
Pathol Biol (Paris) ; 50(3): 161-8, 2002 Apr.
Article in French | MEDLINE | ID: mdl-11980329

ABSTRACT

UNLABELLED: Vancomycin is always the drug of choice for treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in spite of his bactericidal kinetic. BACKGROUND: The aim of this study was to evaluate in vivo the improvement of bactericidal kinetic of vancomycin associated with cefpirome against MRSA infection in critically ill patients. METHODS: The prospective cross-over study was carried out in 20 patients with severe pneumonia or bacteremia. There were randomized to receive vancomycin 2 g per day (Group 1, n = 10) or vancomycin with cefpirome 2 g x 2 (Group 2, n = 10). Clinical recovery, bacteriologic parameters (bactericidal kinetic and bactericidal power in vivo at the peak and the valley), duration of ventilation and stay in ICU were comparatively explored in both groups. RESULTS: Clinical outcome did not significantly differ between Group 1 and 2. Bactericidal kinetics were better in the Group 2 (40% vs 60% after 6 hours to the dilution for 1/8e) but the difference was not significant. However, bactericidal power in sera was also better in the Group 2 with more bactericidal dilution at 1/16e (68% vs 88.8%: NS) and overall at 1/32e (10.5% vs 50%: p < 0.05) and CRP, an inflammatory marker, was significantly lower in the Group 2 than in the Group 1 (119.5 +/- 24 mg/l vs 198.6 +/- 78 mg/l: p < 0.05) on the third day.


Subject(s)
Bacteremia/drug therapy , Cephalosporins/therapeutic use , Critical Care , Drug Therapy, Combination/therapeutic use , Pneumonia, Bacterial/drug therapy , Staphylococcal Infections/drug therapy , Vancomycin/therapeutic use , Adult , Aged , Bacteremia/microbiology , Female , Humans , Male , Methicillin Resistance , Middle Aged , Pneumonia, Bacterial/microbiology , Prospective Studies , Staphylococcal Infections/microbiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/growth & development , Staphylococcus aureus/isolation & purification , Treatment Outcome , Vancomycin/blood , Cefpirome
9.
Pathol Biol (Paris) ; 47(5): 483-5, 1999 May.
Article in French | MEDLINE | ID: mdl-10418023

ABSTRACT

The bactericidal activity of beta-lactams is time-dependent, and the time spent above the MIC (T > MIC) is the best predictor of efficacy. A prospective, randomized, open-label study was conducted in intensive care unit (ICU) patients with gram-negative rod infections to compare the efficacy of cefepime given as a continuous versus an intermittent infusion. Of the 18 patients included to date, 14 had severe pneumonia and four bacteremia. All patients received amikacin, 15 mg/kg/d, and cefepime, 4 g/d. Patients were randomized to cefepime administration as a continuous infusion (Group 1, n = 9) or as an intermittent infusion (Group 2, n = 9, 2 g every 12 h). No significant differences were found between the two groups for age, sex, initial infection, IGS II score (46 vs 48, NS) or the MIC of the gram-negative organism. Mechanical ventilation and hospital stay durations, recovery rates, and pharmacokinetic parameters (24-h AUIC, 12-h AUIC, T > MIC, and T > 5 x MIC) were compared in the two groups using the chi-square and Mann-Whitney tests. P values < 0.05 were considered statistically significant. There were no significant differences for mechanical ventilation duration, recovery rate, hospital stay duration (34 vs 36 days, NS), 24-h AUIC (624 vs 473, NS), or the 12-h AUIC (235 vs 238, NS). There were two interesting findings: T > MIC was significantly (P < 0.05) higher in Group 1 (23.84 +/- 0.2) than in Group 2 (20.7 +/- 3), and T > 5 x MIC was also significantly (P < 0.01) higher in Group 1 (23.61 +/- 0.6) than in Group 2 (16.6 +/- 6). Although clinical outcomes were similar in the two groups, it is reasonable to assume that the longer time spent with a cefepime level above the MIC in the continuous infusion group was associated with a more stable bactericidal effect.


Subject(s)
Bacteremia/drug therapy , Cephalosporins/therapeutic use , Critical Care , Gram-Negative Bacterial Infections/drug therapy , Cefepime , Cephalosporins/administration & dosage , Cephalosporins/pharmacokinetics , Drug Administration Schedule , Female , Humans , Infusions, Intravenous , Length of Stay , Male , Middle Aged
10.
Arch Mal Coeur Vaiss ; 91(10): 1277-81, 1998 Oct.
Article in French | MEDLINE | ID: mdl-9833093

ABSTRACT

The authors report two cases of Bartonella endocarditis in native valves. The first case was a 15 year old North African Girl who lived in poor social conditions and was admitted to hospital with pyrexia and congestive heart failure. Investigations revealed massive mitral regurgitation due to ruptured chordae tendinae, vegetations on the pulmonary valve with severe pulmonary hypertension due to persistent ductus arteriosus. After antibiotic therapy, the patient underwent surgery for mitral valve replacement, pulmonary valvuloplasty and closure of the patent ductus arteriosus. The second case was a 39 year old man with no fixed abode with a history of alcoholism who presented with a recurrent ischaemic stroke in a context of infection with a murmur of aortic regurgitation. Echocardiography showed a vegetation on the aortic valve with grade III/IV regurgitation requiring aortic valve replacement with a homograft after antibiotic therapy. The aetiological diagnosis was made a posteriori by the finding of high antibody titres and specific genetic amplification of Bartonella. In patients with negative blood cultures, Bartonella infection should be looked for systematically especially in those living under poor social conditions. The practical diagnostic investigation of endocarditis with negative blood cultures is reviewed.


Subject(s)
Bartonella Infections/microbiology , Endocarditis, Bacterial/microbiology , Mitral Valve Insufficiency/etiology , Pulmonary Valve Insufficiency/etiology , Adolescent , Adult , Algeria , Bartonella Infections/complications , Bartonella Infections/diagnostic imaging , Bartonella quintana/isolation & purification , Echocardiography , Endocarditis, Bacterial/complications , Endocarditis, Bacterial/diagnostic imaging , Female , Heart Valve Prosthesis Implantation , Humans , Male , Mitral Valve Insufficiency/diagnostic imaging , Mitral Valve Insufficiency/microbiology , Mitral Valve Insufficiency/surgery , Pulmonary Valve Insufficiency/microbiology
12.
Presse Med ; 26(11): 502-6, 1997 Apr 05.
Article in French | MEDLINE | ID: mdl-9137379

ABSTRACT

OBJECTIVES: To evaluate the development of resistance to fosfomycin or fucidic acid in severe infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and to assess the relationship with serum levels of vancomycin METHODS: A retrospective study was performed in patients hospitalized in our intensive care unit during a 3-year period (1993-1995) who were treated for severe MRSA infection with continuous infusion vacomycin and fosfomycin or fucidic acid. We analyzed the development of resistance and serum levels of vancomycin. RESULTS: During this period, only 20 patients received continuous infusion vancomycin plus fucidic acid or fosfomycin. MSRA resistant to fucidic or fosfomycin developed in 9. Vancomycin serum levels were significantly lower in patients who developed resistance to focidic acid or fosfomycin, both during the first 5 days of treatment (16.68 +/- 1.07 micrograms/ml vs. 22.64 +/- 1.05 mg/ml, p < 0.01) and throughout treatment duration (17.29 +/- 1.07 micrograms/ml vs. 21.85 +/- 0.78 microgram/ml, p < 0.01). CONCLUSIONS: Our findings confirm that in spite of continuous vancomycin infusion at an initial rate of 2 g/24 h, Staphylococcus aureus resistance to fosfomycin or fucidic acid an develop during ongoing treatment. Vancomycin levels of at least 20 micrograms/ml should be obtained as rapidly as possible.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Drug Resistance, Multiple , Methicillin Resistance , Staphylococcal Infections/drug therapy , Vancomycin/therapeutic use , Anti-Bacterial Agents/administration & dosage , Drug Therapy, Combination/administration & dosage , Drug Therapy, Combination/therapeutic use , Female , Fosfomycin/administration & dosage , Fosfomycin/therapeutic use , Fusidic Acid/administration & dosage , Fusidic Acid/therapeutic use , Humans , Infusions, Intravenous , Male , Middle Aged , Retrospective Studies , Time Factors , Vancomycin/administration & dosage
13.
Rev Prat ; 43(9): 1069-71, 1993 May 01.
Article in French | MEDLINE | ID: mdl-8378713

ABSTRACT

The possibility that have certain strains of Escherichia coli to adhere to the urinary epithelium, constitutes a real pathogenic character. This adhesivity is specific and occurs through proteic structures (adhesins), that are present on the surface of bacteria and which recognize complementary receptors on uroepithelial cells. Studies of the frequency of these adhesins in different types of urinary tract infections, as well as experimental studies in animals all point towards an important role played by adhesins in the pathogenesis of the upper urinary tract infection.


Subject(s)
Bacterial Adhesion , Escherichia coli/pathogenicity , Urinary Tract Infections/microbiology , Animals , Escherichia coli/physiology , Urinary Tract Infections/physiopathology , Virulence
14.
Rev Neurol (Paris) ; 149(6-7): 411-5, 1993.
Article in French | MEDLINE | ID: mdl-8303161

ABSTRACT

The pathogenic mechanisms underlying Lyme disease remain uncertain but an increasing number of reports suggest a vascular inflammatory process. On the other hand, the so-called systemic vasculitides, even though they remain of pathological definition, have recently been characterized by the presence, in the serum, of anti-neutrophil cytoplasmic antibodies (ANCA). We report on a patient, finally diagnosed as having neuroborreliosis, who presented initially with multiple mononeuropathy, ANCA, vascular lesions at muscle biopsy and lymphocytic meningitis. Despite antibiotherapy, he presented with two recurrent strokes, from which he completely recovered. He also developed oto-sinusitis. The disease was finally clinically and biologically controlled by immunosuppressive therapy. The relationship between angiitis and Lyme disease are discussed. It is hypothesized that Borrelia burgdorferi infection may cause a systemic vasculitis following its own course and requiring its own treatment.


Subject(s)
Lyme Disease/complications , Meningitis, Bacterial/etiology , Neuritis/etiology , Peripheral Nervous System Diseases/etiology , Vasculitis/etiology , Aged , Antibodies, Antineutrophil Cytoplasmic , Autoantibodies/immunology , Cerebral Angiography , Cyclophosphamide/therapeutic use , Diagnosis, Differential , Granulomatosis with Polyangiitis/immunology , Humans , Immunoglobulin G/immunology , Lyme Disease/drug therapy , Lyme Disease/immunology , Male , Meningitis, Bacterial/immunology , Neuritis/immunology , Peripheral Nervous System Diseases/immunology , Prednisolone/therapeutic use , Vasculitis/immunology
15.
J Clin Microbiol ; 30(5): 1189-93, 1992 May.
Article in English | MEDLINE | ID: mdl-1349900

ABSTRACT

Adhesin-encoding operons (pap, sfa/foc, and afa) have been shown to be prevalent in Escherichia coli strains associated with urinary tract infections. A quick and sensitive assay to identify these operons was developed by using the polymerase chain reaction (PCR). Three pairs of 25-mer primers were defined from the sequences of the DNA fragments used as probes in hybridization studies to identify each of the three operons, and the six primers were used together in a single reaction of amplification. To validate the PCR approach for detection of adhesin-encoding operons among clinical isolates, we investigated a collection of 97 E. coli isolates with the following characteristics: all isolates originated from the urine of patients with pyelonephritis, and the adhesin responsible for specific binding of the isolates to uroepithelial cells was previously characterized by phenotypic assays, as well as genotypic tests based on hybridization. There was a perfect correlation between the results obtained with the PCR approach and those previously obtained by using DNA probes. These results indicate that the PCR method, which is highly specific and easier to perform than the hybridization method, is a powerful genotypic assay for detection of adhesin-encoding operons. Thus, this assay can be recommended for clinical use to detect virulent urinary E. coli strains, as well as for epidemiological studies.


Subject(s)
Bacterial Outer Membrane Proteins/genetics , Escherichia coli/genetics , Operon , Polymerase Chain Reaction , Adhesins, Escherichia coli , Base Sequence , DNA, Bacterial/chemistry , Molecular Sequence Data
16.
Pathol Biol (Paris) ; 39(5): 424-8, 1991 May.
Article in French | MEDLINE | ID: mdl-1652730

ABSTRACT

The in vitro susceptibility of nine Rhodococcus equi strains (seven isolates from immunocompromised patients mainly HIV positive and two reference strains) to twenty various antibiotics were assessed for bacteriostatic effects by an agar dilution method. Imipenem and ceftriaxone were the most effective of the beta-lactams studied. The lowest MIC were noted with vancomycin, teicoplanin, erythromycin, clarithromycin, rifampicin, gentamicin and doxycycline. A longitudinal survey, including three strains isolated from the same patient, showed the emergence of rifampicin resistance and a marked increase of the MIC to imipenem.


Subject(s)
Aminoglycosides/pharmacology , Anti-Bacterial Agents/pharmacology , Quinolones/pharmacology , Rhodococcus/drug effects , Actinomycetales Infections/complications , Actinomycetales Infections/microbiology , Dose-Response Relationship, Drug , Doxycycline/pharmacology , Drug Resistance, Microbial , HIV Infections/complications , Humans , In Vitro Techniques , Lactams , Macrolides , Opportunistic Infections/complications , Opportunistic Infections/microbiology , Rhodococcus/isolation & purification , Rifampin/pharmacology
17.
J Antimicrob Chemother ; 27(4): 427-36, 1991 Apr.
Article in English | MEDLINE | ID: mdl-1856122

ABSTRACT

Salmonella kedougou BM2659 was isolated from the stools and a blood culture of a patient and Klebsiella pneumoniae BM2657 and S. kedougou BM2658 were isolated later from the stools of the same patient. Strains BM2657 and BM2658 had identical resistance phenotypes, to beta-lactams, aminoglycosides and tetracycline, due to the presence of the same genes, blaT, aacA4 and tetC, respectively. Oligotyping indicating that beta-lactam resistance in these strains was encoded by blaT-3 and synthesis of TEM-3 was confirmed by isoelectric focusing. In BM2657 and BM2658, the resistance characters were located on Inc7 or M self-transferable plasmids with indistinguishable EcoRI and HindIII restriction patterns. Southern hybridization of plasmid DNA of these strains with probes pCFFO4, the prototype plasmid encoding TEM-3, genes blaT, aacA4 and tetC gave identical patterns. S. kedougou BM2658 and BM2659 had identical biotypes and serotypes but BM2659 was susceptible to all the study antibiotics. These observations suggest possible transfer, in the digestive tract, of a plasmid encoding TEM-3 beta-lactamase from K. pneumoniae BM2657 to S. kedougou BM2659.


Subject(s)
Klebsiella pneumoniae/enzymology , Salmonella/enzymology , beta-Lactamases/genetics , Anti-Bacterial Agents/pharmacology , Conjugation, Genetic , Culture Media , DNA, Bacterial/analysis , DNA, Bacterial/isolation & purification , Digestive System/microbiology , Drug Resistance, Microbial/genetics , Electrophoresis, Polyacrylamide Gel , Isoelectric Focusing , Klebsiella pneumoniae/genetics , Microbial Sensitivity Tests , Nucleic Acid Hybridization , Phenotype , Plasmids , Salmonella/genetics , Transfection , beta-Lactamases/biosynthesis
18.
Pathol Biol (Paris) ; 37(5 Pt 2): 534-9, 1989 Jun.
Article in French | MEDLINE | ID: mdl-2677925

ABSTRACT

Bactericidal activity of gentamicin, imipenem, ciprofloxacin and cefotaxime associated with sulbactam are studied on 36 beta lactamase CTX-1 (TEM-3) producing Klebsiella pneumoniae strains isolated of sputum samples and urines, among patients of intensive care units, in Rangueil hospital (Toulouse). Gentamicin, imipenem, cefotaxime associated with sulbactam have a bactericidal activity at serum levels, obtained with usual therapeutic doses. Ciprofloxacin has a bactericidal activity at concentrations obtained in urine and into lung tissue. Killing curve method was used to study bactericidal activity of these antibiotics alone and in combination, on a representative sample. Alone gentamicin showed the most rapid bactericidal activity (2 hours). The associations with gentamicin are also rapidly bactericidal. The associations with ciprofloxacin and imipenem, ciprofloxacin and cefotaxime/sulbactam are synergistic.


Subject(s)
Cefotaxime/pharmacology , Ciprofloxacin/pharmacology , Gentamicins/pharmacology , Imipenem/pharmacology , Klebsiella pneumoniae/drug effects , Sulbactam/pharmacology , Drug Synergism , Drug Therapy, Combination
19.
Rev Fr Gynecol Obstet ; 84(3): 201-4, 1989 Mar 10.
Article in French | MEDLINE | ID: mdl-2717852

ABSTRACT

The authors sometimes see cervico-vaginal smears with too many white cells. The question is: what is the meaning of these smears, and what must be the physician's attitude? The authors try to answer this question in this paper. They find 8 p. cent of genital tract infections in their observations.


Subject(s)
Genital Diseases, Female/pathology , Neutrophils/analysis , Vaginal Smears , Female , Genital Diseases, Female/etiology , Humans , Leukocyte Count
20.
Ann Inst Pasteur Microbiol ; 139(5): 575-88, 1988.
Article in English | MEDLINE | ID: mdl-3075501

ABSTRACT

The genetic determinants responsible for the adherence of Escherichia coli to uroepithelial cells have been identified in recent years by genetic and molecular methods. Specific DNA probes for each of the three operons which have been cloned so far (pap, afa, sfa/foc operons) have been used in colony hybridization experiments to detect the presence of each of these operons in the chromosomal DNA of 443 strains of E. coli; 186 strains were from patients with urinary tract infections (pyelonephritis, 106 strains; cystitis, 59; asymptomatic bacteriuria, 21) and 257 were strains from the stools of healthy subjects (61) or from patients with various enteral infections (196). E. coli strains harbouring the pap operon were found more frequently in the urine of patients with pyelonephritis (p less than 0.001) and cystitis (p less than 0.01) than in control stools. The presence of two operons (pap + afa) or (pap + sfa/foc) was only observed in uropathogenic strains (p less than 0.02). Pap and sfa/foc operons were never found in strains causing enteral infection; however, the afa operon was found in 7.6% of the enteropathogenic E. coli.


Subject(s)
Adhesins, Bacterial , Bacterial Adhesion , Escherichia coli Infections/microbiology , Escherichia coli/genetics , Intestinal Diseases/microbiology , Polysaccharides, Bacterial/genetics , Urinary Tract Infections/microbiology , Child , Cystitis/microbiology , DNA Probes , DNA, Bacterial/analysis , Escherichia coli/analysis , Female , Humans , Nucleic Acid Hybridization , Operon , Polysaccharides, Bacterial/analysis , Pyelonephritis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...